Literature DB >> 1792001

Reduced protein kinase C activity in sporadic Alzheimer's disease fibroblasts.

A Bruel1, G Cherqui, S Columelli, D Margelin, M Roudier, P M Sinet, M Prieur, J L Pérignon, J Delabar.   

Abstract

A decrease in the protein kinase C immunoreactivity and an altered protein phosphorylation have been reported in patients with Alzheimer's disease, but discordant results have been obtained from determinations of protein kinase C activity. By assaying the calcium- and phospholipid-dependent phosphorylation of a lysine-rich histone after detergent extraction, we have determined the total protein kinase C activity in fibroblasts from patients with sporadic Alzheimer's disease, age-matched controls and young subjects. The activity was not significantly different between young and aged controls, whereas it was significantly lower (0.70 +/- 0.12 vs 1.16 +/- 0.23 nmol/min/mg protein, P less than 0.01) in the patients. The total amount of protein kinase C estimated from the binding of phorbol dibutyrate to intact cells was also significantly lower (1.70 +/- 0.41 vs 2.48 +/- 0.54 pmol/mg protein, P less than 0.01). This decrease in protein kinase C activity suggests that abnormal protein phosphorylation might play a role in the pathogenesis of the disease.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1792001     DOI: 10.1016/0304-3940(91)90064-z

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  6 in total

1.  Alzheimer's-specific effects of soluble beta-amyloid on protein kinase C-alpha and -gamma degradation in human fibroblasts.

Authors:  A Favit; M Grimaldi; T J Nelson; D L Alkon
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-12       Impact factor: 11.205

2.  Bradykinin-induced amyloid precursor protein secretion: a protein kinase C-independent mechanism that is not altered in fibroblasts from patients with sporadic Alzheimer's disease.

Authors:  M Racchi; P Ianna; G Binetti; M Trabucchi; S Govoni
Journal:  Biochem J       Date:  1998-03-15       Impact factor: 3.857

3.  Cardiorespiratory fitness and brain atrophy in early Alzheimer disease.

Authors:  J M Burns; B B Cronk; H S Anderson; J E Donnelly; G P Thomas; A Harsha; W M Brooks; R H Swerdlow
Journal:  Neurology       Date:  2008-07-15       Impact factor: 9.910

Review 4.  Is Alzheimer's disease a systemic disease?

Authors:  Jill K Morris; Robyn A Honea; Eric D Vidoni; Russell H Swerdlow; Jeffrey M Burns
Journal:  Biochim Biophys Acta       Date:  2014-04-18

Review 5.  Disturbances in signal transduction mechanisms in Alzheimer's disease.

Authors:  C J Fowler; R F Cowburn; A Garlind; B Winblad; C O'Neill
Journal:  Mol Cell Biochem       Date:  1995 Aug-Sep       Impact factor: 3.396

6.  Protein Kinase Activity Decreases with Higher Braak Stages of Alzheimer's Disease Pathology.

Authors:  Andrea F N Rosenberger; Riet Hilhorst; Elisabeth Coart; Leandro García Barrado; Faris Naji; Annemieke J M Rozemuller; Wiesje M van der Flier; Philip Scheltens; Jeroen J M Hoozemans; Saskia M van der Vies
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.